Dividend Stocks To Follow Today – May 2nd

ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Chevron, Exxon Mobil, Amgen, AbbVie, and Texas Instruments are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their earnings to shareholders in the form of dividends. These payouts are typically made on a quarterly basis and can provide investors with a steady income stream in addition to any potential capital gains. Companies that pay dividends are often mature, financially stable businesses with predictable cash flows. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

ProShares UltraPro Short QQQ stock traded down $1.44 during trading hours on Friday, hitting $28.57. The company had a trading volume of 90,314,856 shares, compared to its average volume of 88,102,211. The company has a 50-day moving average price of $36.80 and a two-hundred day moving average price of $33.08. ProShares UltraPro Short QQQ has a 1 year low of $26.21 and a 1 year high of $57.95.

Direxion Daily TSLA Bull 2X Shares (TSLL)

NASDAQ TSLL traded up $0.64 on Friday, reaching $10.74. 207,196,549 shares of the stock traded hands, compared to its average volume of 86,916,220. Direxion Daily TSLA Bull 2X Shares has a 12 month low of $6.29 and a 12 month high of $41.50. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 48.19 and a beta of -5.14. The company has a fifty day moving average price of $9.58 and a 200-day moving average price of $18.23.

Chevron (CVX)

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.

Chevron stock traded up $1.82 during midday trading on Friday, hitting $138.08. 9,213,213 shares of the company’s stock were exchanged, compared to its average volume of 7,975,512. Chevron has a 12 month low of $132.04 and a 12 month high of $168.96. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.80 and a current ratio of 1.07. The company has a market cap of $243.11 billion, a PE ratio of 14.21, a P/E/G ratio of 1.46 and a beta of 0.93. The firm has a 50-day moving average of $150.11 and a two-hundred day moving average of $152.59.

Exxon Mobil (XOM)

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.

Exxon Mobil stock traded down $0.02 during mid-day trading on Friday, reaching $105.77. 10,972,301 shares of the company were exchanged, compared to its average volume of 15,787,724. The firm has a market cap of $457.46 billion, a P/E ratio of 13.50, a PEG ratio of 3.02 and a beta of 0.61. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.97 and a current ratio of 1.31. Exxon Mobil has a 12-month low of $97.80 and a 12-month high of $126.34. The business has a fifty day moving average of $109.44 and a 200 day moving average of $111.83.

Amgen (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.

AMGN traded down $2.95 on Friday, hitting $280.83. The company had a trading volume of 2,838,324 shares, compared to its average volume of 3,138,136. The stock has a market capitalization of $150.99 billion, a price-to-earnings ratio of 37.19, a P/E/G ratio of 2.63 and a beta of 0.51. The stock has a fifty day moving average price of $300.34 and a 200-day moving average price of $291.79. Amgen has a 12-month low of $253.30 and a 12-month high of $346.85. The company has a debt-to-equity ratio of 9.62, a quick ratio of 0.95 and a current ratio of 1.26.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

NYSE ABBV traded up $4.79 on Friday, hitting $198.13. The stock had a trading volume of 3,868,825 shares, compared to its average volume of 6,070,743. AbbVie has a 52-week low of $153.58 and a 52-week high of $218.66. The business’s fifty day moving average price is $196.25 and its 200 day moving average price is $187.20. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. The stock has a market cap of $350.49 billion, a price-to-earnings ratio of 82.56, a price-to-earnings-growth ratio of 1.62 and a beta of 0.56.

Texas Instruments (TXN)

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.

TXN stock traded up $6.29 on Friday, hitting $164.55. 4,303,451 shares of the company’s stock were exchanged, compared to its average volume of 6,187,079. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.88 and a current ratio of 4.12. The stock has a market cap of $149.73 billion, a P/E ratio of 31.71, a price-to-earnings-growth ratio of 3.30 and a beta of 0.99. The firm has a 50 day moving average price of $170.98 and a two-hundred day moving average price of $186.58. Texas Instruments has a 12-month low of $139.95 and a 12-month high of $220.39.